OMCL vs. MDT
OMCL (Omnicell, Inc.) and MDT (Medtronic plc) are both stocks. Both are in the Healthcare sector — OMCL in Health Information Services, MDT in Medical Devices. Over the past 10 years, OMCL returned 2.47%/yr vs 2.40%/yr for MDT. At a 0.28 correlation, their price movements are largely independent.
Performance
OMCL vs. MDT - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, OMCL achieves a -5.08% return, which is significantly higher than MDT's -14.29% return. Both investments have delivered pretty close results over the past 10 years, with OMCL having a 2.47% annualized return and MDT not far behind at 2.40%.
OMCL
- 1D
- -1.38%
- 1M
- -1.74%
- YTD
- -5.08%
- 6M
- 6.19%
- 1Y
- 39.29%
- 3Y*
- -16.72%
- 5Y*
- -20.98%
- 10Y*
- 2.47%
MDT
- 1D
- -0.32%
- 1M
- 5.24%
- YTD
- -14.29%
- 6M
- -18.17%
- 1Y
- -3.14%
- 3Y*
- 2.50%
- 5Y*
- -5.14%
- 10Y*
- 2.40%
OMCL vs. MDT - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
OMCL Omnicell, Inc. | -5.08% | 1.75% | 18.31% | -25.37% | -72.06% | 50.34% | 46.87% | 33.44% | 26.27% | 43.07% |
MDT Medtronic plc | -14.29% | 24.05% | 0.28% | 9.58% | -22.55% | -9.79% | 5.70% | 27.34% | 15.18% | 15.90% |
Correlation
The correlation between OMCL and MDT is 0.14, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.14 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.27 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.31 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.33 |
Correlation (All Time) Calculated using the full available price history since Aug 10, 2001 | 0.28 |
The correlation between OMCL and MDT shifts across timeframes, from 0.14 (1 year) to 0.33 (10 years), reflecting how their relationship changes across market environments.
Fundamentals
OMCL:
$1.98B
MDT:
$105.21B
OMCL:
$0.44
MDT:
$3.58
OMCL:
96.94
MDT:
22.79
OMCL:
5.79
MDT:
2.06
OMCL:
1.62
MDT:
2.96
OMCL:
$1.23B
MDT:
$35.48B
OMCL:
$532.87M
MDT:
$5.78B
OMCL:
$98.25M
MDT:
$7.11B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
OMCL vs. MDT — Risk / Return Rank
OMCL
MDT
OMCL vs. MDT - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Omnicell, Inc. (OMCL) and Medtronic plc (MDT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| OMCL | MDT | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.99 | ||
| Sortino ratioReturn per unit of downside risk | +1.58 | ||
| Omega ratioGain probability vs. loss probability | 1.20 | 0.99 | +0.20 |
| Calmar ratioReturn relative to maximum drawdown | 1.07 | -0.11 | +1.17 |
| Martin ratioReturn relative to average drawdown | 2.58 | -0.28 | +2.86 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| OMCL | MDT | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.83 | -0.15 | +0.99 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.42 | -0.24 | -0.18 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.06 | 0.10 | -0.05 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.13 | 0.47 | -0.34 |
Drawdowns
OMCL vs. MDT - Drawdown Comparison
The maximum OMCL drawdown since its inception was -86.67%, which is greater than MDT's maximum drawdown of -57.63%. Use the drawdown chart below to compare losses from any high point for OMCL and MDT.
Loading charts...
Drawdown Indicators
| OMCL | MDT | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -86.67% | -57.63% | -29.04% |
Max Drawdown (1Y)Largest decline over 1 year | -37.05% | -28.90% | -8.15% |
Max Drawdown (3Y)Largest decline over 3 years | -67.57% | -28.90% | -38.67% |
Max Drawdown (5Y)Largest decline over 5 years | -86.59% | -45.10% | -41.49% |
Max Drawdown (10Y)Largest decline over 10 years | -86.59% | -45.10% | -41.49% |
Current DrawdownCurrent decline from peak | -76.58% | -29.97% | -46.61% |
Average DrawdownAverage peak-to-trough decline | -37.30% | -16.54% | -20.76% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 15.29% | 11.08% | +4.21% |
Volatility
OMCL vs. MDT - Volatility Comparison
The current volatility for Omnicell, Inc. (OMCL) is 8.90%, while Medtronic plc (MDT) has a volatility of 9.94%. This indicates that OMCL experiences smaller price fluctuations and is considered to be less risky than MDT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| OMCL | MDT | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 8.90% | 9.94% | -1.04% |
Volatility (6M)Calculated over the trailing 6-month period | 38.30% | 16.16% | +22.14% |
Volatility (1Y)Calculated over the trailing 1-year period | 47.32% | 20.95% | +26.37% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 50.21% | 21.92% | +28.29% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 43.83% | 23.23% | +20.60% |
Dividends
OMCL vs. MDT - Dividend Comparison
OMCL has not paid dividends to shareholders, while MDT's dividend yield for the trailing twelve months is around 3.48%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
MDT Medtronic plc | 3.48% | 2.95% | 3.49% | 3.34% | 3.44% | 2.39% | 1.95% | 1.87% | 2.15% | 2.24% | 2.34% | 1.88% |
OMCL Omnicell, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
OMCL vs. MDT - Financials Comparison
This section allows you to compare key financial metrics between Omnicell, Inc. and Medtronic plc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
OMCL and MDT have a correlation of 0.14, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
MDT has higher volatility (9.94%) compared to OMCL (8.90%). In terms of maximum drawdown, OMCL dropped -86.67% vs MDT's -57.63%.
OMCL currently has the higher Sharpe Ratio (0.83 vs -0.15), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for OMCL and MDT
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer